We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Exposure to Arsenic in Drinking Water is Associated with Increased Prevalence of Diabetes: A Cross-Sectional Study in the Zimapan and Lagunera Regions in Mexico
News

Exposure to Arsenic in Drinking Water is Associated with Increased Prevalence of Diabetes: A Cross-Sectional Study in the Zimapan and Lagunera Regions in Mexico

Exposure to Arsenic in Drinking Water is Associated with Increased Prevalence of Diabetes: A Cross-Sectional Study in the Zimapan and Lagunera Regions in Mexico
News

Exposure to Arsenic in Drinking Water is Associated with Increased Prevalence of Diabetes: A Cross-Sectional Study in the Zimapan and Lagunera Regions in Mexico

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Exposure to Arsenic in Drinking Water is Associated with Increased Prevalence of Diabetes: A Cross-Sectional Study in the Zimapan and Lagunera Regions in Mexico"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Background:
Human exposures to inorganic Arsenic (iAs) have been linked to an increased risk of diabetes mellitus. Recent laboratory studies showed that methylated trivalent metabolites of iAs may play key roles in the diabetogenic effects of iAs. Our study examined associations between chronic exposure to iAs in drinking water, metabolism of iAs, and prevalence of diabetes in Arsenicosis-endemic areas of Mexico.

Methods:
We used fasting blood glucose (FBG), fasting plasma insulin (FPI), oral glucose tolerance test (OGTT), glycated hemoglobin (HbA1c), and insulin resistance (HOMA-IR) to characterize diabetic individuals. Arsenic levels in drinking water and urine were determined to estimate exposure to iAs. Urinary concentrations of iAs and its trivalent and pentavalent methylated metabolites were measured to assess iAs metabolism. Associations between diabetes and iAs exposure or urinary metabolites of iAs were estimated by logistic regression with adjustment for age, sex, hypertension and obesity.

Results:
The prevalence of diabetes was positively associated with iAs in drinking water (OR 1.13 per 10 ppb, p < 0.01) and with the concentration of dimethylarsinite (DMAsIII) in urine (OR 1.24 per inter-quartile range, p = 0.05). Notably, FPI and HOMA-IR were negatively associated with iAs exposure (beta -2.08 and -1.64, respectively, p < 0.01), suggesting that the mechanisms of iAs-induced diabetes differ from those underlying type-2 diabetes, which is typically characterized by insulin resistance.

Conclusions:
Our study confirms a previously reported, but frequently questioned, association between exposure to iAs and diabetes, and is the first to link the risk of diabetes to the production of one of the most toxic metabolites of iAs, DMAsIII.

The article is published online in the journal Environmental Health and is free to access.

Advertisement